Lisata Therapeutics, Inc.
LSTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,249 | -$4,659 | -$4,724 | -$4,610 |
| Dep. & Amort. | $44 | $44 | $43 | $41 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $530 | $872 |
| Change in WC | $645 | $440 | -$1,210 | $358 |
| Other Non-Cash | $218 | $219 | -$41 | -$1,189 |
| Operating Cash Flow | -$3,342 | -$3,956 | -$5,402 | -$4,528 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$28 | -$28 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $130 |
| Inv. Purchases | $0 | -$4,097 | -$5,055 | -$11,735 |
| Inv. Sales/Matur. | $5,150 | $4,630 | $14,514 | $13,124 |
| Other Inv. Act. | $0 | $0 | $0 | -$130 |
| Investing Cash Flow | $5,150 | $505 | $9,431 | $1,389 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $353 | $74 | $212 | $36 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$10 | -$235 | -$132 |
| Financing Cash Flow | $353 | $64 | -$23 | -$96 |
| Forex Effect | $2 | $5 | $2 | -$65 |
| Net Chg. in Cash | $2,163 | -$3,382 | $4,008 | -$3,300 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16,835 | $20,217 | $16,209 | $19,509 |
| End Cash | $18,998 | $16,835 | $20,217 | $16,209 |
| Free Cash Flow | -$3,342 | -$3,984 | -$5,430 | -$4,528 |